Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yutaka Obuchi

1PUBLICATIONS

12CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jun 12, 2024

A PDE3A-SLFN12 Molecular Glue Exhibits Significant Antitumor Activity in TKI-Resistant Gastrointestinal Stromal Tumors.

Emiri O Takaki, Kunihiko Kiyono, Yutaka Obuchi

Pageof 1

Frequent Collaborators

1 joint publications

Emiri O Takaki

1 joint publications

Kunihiko Kiyono

1 joint publications

Takeshi Yamauchi

1 joint publications

Takashi Watanabe

1 joint publications

Hideki Matsumoto

1 joint publications

Miho Karimine

1 joint publications

Yuki Kuniyoshi

1 joint publications

Shingo Nishikori

1 joint publications

Fumiharu Yokoyama

1 joint publications

Hikaru Nishimori

Frequent Collaborators

1 joint publications

Emiri O Takaki

1 joint publications

Kunihiko Kiyono

1 joint publications

Takeshi Yamauchi

1 joint publications

Takashi Watanabe

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos